ライフサイエンスコーパス: adjuvant arthritis

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 apacity of MTX to ameliorate inflammation in adjuvant arthritis.

2 has been invoked in the pathogenesis of both adjuvant arthritis (AA) in the Lewis rat (RT.1(l)) and h

3 Adjuvant arthritis (AA) induced in the Lewis rat (RT-1(l

4 Adjuvant arthritis (AA) is inducible in susceptible rat

5 Adjuvant arthritis (AA) was induced in Lewis male rats b

6 Adjuvant arthritis (AA) was induced in Lewis rats preimm

7 dn significantly ameliorated the severity of adjuvant arthritis, accompanied by a significant decreas

8 essing autoimmune arthritis in the models of adjuvant arthritis and collagen-induced arthritis in rat

9 ent role in the inflammation associated with adjuvant arthritis and that COX-2 derived PGs upregulate

10 necessary for maximal joint inflammation in adjuvant arthritis but could be replaced by synthetic IS

11 ating the bone resorption that occurs in rat adjuvant arthritis, but is less important in the pathoge

12 The results of this study indicate that adjuvant arthritis has a metabolic cost, which increases

13 hether ISS contributes to the development of adjuvant arthritis in Lewis rats after intradermal injec

14 on of collagen-induced arthritis in mice and adjuvant arthritis in Lewis rats.

15 s further demonstrated in a chronic model of adjuvant arthritis in rats with established disease when

16 lso been shown to be effective in inhibiting adjuvant arthritis in the rat.

17 Thus, adjuvant arthritis is a microbial DNA-dependent disease.

18 e has shown that streptococcal arthritis and adjuvant arthritis may be related to epitopes shared bet

19 ed, using the intraarticular complete Freund adjuvant arthritis mice model, whether the radiotracer (

20 se, exhibiting good efficacy in both the rat adjuvant arthritis model (AA) and the mouse experimental

21 y of IL-4 and IL-10 was measured using a rat adjuvant arthritis model in which the mycobacterial anti

22 e and caffeine, were examined, using the rat adjuvant arthritis model of RA.

23 ic signs of disease, was achieved in the rat adjuvant arthritis model with doses of INCB028050 provid

24 ced TNFalpha pharmacodynamic model and a rat adjuvant arthritis model, 2 demonstrated similar efficac

25 In the rat adjuvant arthritis model, treatment with systemic murine

26 l efficacy when administered orally in a rat adjuvant arthritis model.

27 (JNK) decreases joint destruction in the rat adjuvant arthritis model.

28 rimental allergic encephalitis and the Lewis adjuvant arthritis model.

29 dema assay and reduced paw swelling in a rat adjuvant arthritis model.

30 type II collagen arthritis model and the rat adjuvant arthritis model.

31 lerability when administered orally in a rat adjuvant arthritis model.

32 Rats with developing adjuvant arthritis or established collagen-induced arthr

33 ntiinflammatory effects were observed in the adjuvant arthritis rats treated with IL-1Ra.

34 vels were correlated with suppression of rat adjuvant arthritis regardless of the drug or dose level

35 nducible COX-2 enzyme to inflammation in rat adjuvant arthritis was evaluated by characterization of

36 Adjuvant arthritis was induced in a group of 10 female L

37 Dose-dependent effects in rat adjuvant arthritis were determined by histologic and cli

38 xperimental autoimmune encephalomyelitis and adjuvant arthritis were significantly more severe in rat

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。